OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du, Arnold Piek, Elisabeth M. Schouten, et al.
Theranostics (2018) Vol. 8, Iss. 15, pp. 4155-4169
Open Access | Times Cited: 84
Weijie Du, Arnold Piek, Elisabeth M. Schouten, et al.
Theranostics (2018) Vol. 8, Iss. 15, pp. 4155-4169
Open Access | Times Cited: 84
Showing 1-25 of 84 citing articles:
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4229-4361
Open Access | Times Cited: 1556
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4229-4361
Open Access | Times Cited: 1556
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
Radek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 11, pp. 1966-1983
Open Access | Times Cited: 256
Radek Pudil, Christian Mueller, Jelena Čelutkienė, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 11, pp. 1966-1983
Open Access | Times Cited: 256
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 3, pp. 272-285
Open Access | Times Cited: 240
Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 3, pp. 272-285
Open Access | Times Cited: 240
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal - Cardiovascular Imaging (2022) Vol. 23, Iss. 10, pp. e333-e465
Open Access | Times Cited: 210
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, et al.
European Heart Journal - Cardiovascular Imaging (2022) Vol. 23, Iss. 10, pp. e333-e465
Open Access | Times Cited: 210
GDF15: A Hormone Conveying Somatic Distress to the Brain
Sam Lockhart, Vladimı́r Saudek, Stephen O’Rahilly
Endocrine Reviews (2020) Vol. 41, Iss. 4
Open Access | Times Cited: 162
Sam Lockhart, Vladimı́r Saudek, Stephen O’Rahilly
Endocrine Reviews (2020) Vol. 41, Iss. 4
Open Access | Times Cited: 162
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction
Coenraad Withaar, Laura M G Meems, George Markousis‐Mavrogenis, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 9, pp. 2108-2124
Open Access | Times Cited: 159
Coenraad Withaar, Laura M G Meems, George Markousis‐Mavrogenis, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 9, pp. 2108-2124
Open Access | Times Cited: 159
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA ), European Society of Cardiology (ESC )
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1610-1632
Open Access | Times Cited: 115
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1610-1632
Open Access | Times Cited: 115
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology
Julio Núñez, Rafael de la Espriella, Patrick Rossignol, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1751-1766
Open Access | Times Cited: 92
Julio Núñez, Rafael de la Espriella, Patrick Rossignol, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1751-1766
Open Access | Times Cited: 92
Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models
Coenraad Withaar, Carolyn S.P. Lam, Gabriele G. Schiattarella, et al.
European Heart Journal (2021) Vol. 42, Iss. 43, pp. 4420-4430
Open Access | Times Cited: 97
Coenraad Withaar, Carolyn S.P. Lam, Gabriele G. Schiattarella, et al.
European Heart Journal (2021) Vol. 42, Iss. 43, pp. 4420-4430
Open Access | Times Cited: 97
Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression
Xiumeng Hua, Yin‐Ying Wang, Peilin Jia, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 92
Xiumeng Hua, Yin‐Ying Wang, Peilin Jia, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 92
Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure
Nikole J. Byrne, Shubham Soni, Shingo Takahara, et al.
Circulation Heart Failure (2020) Vol. 13, Iss. 6
Open Access | Times Cited: 84
Nikole J. Byrne, Shubham Soni, Shingo Takahara, et al.
Circulation Heart Failure (2020) Vol. 13, Iss. 6
Open Access | Times Cited: 84
Sex‐related differences in contemporary biomarkers for heart failure: a review
Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 5, pp. 775-788
Open Access | Times Cited: 83
Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 5, pp. 775-788
Open Access | Times Cited: 83
Gender-Related Differences in Heart Failure Biomarkers
Germán Cediel, Pau Codina, Giosafat Spitaleri, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 56
Germán Cediel, Pau Codina, Giosafat Spitaleri, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 56
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 51
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 51
Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?
Lauriane Cornuault, Paul Rouault, Cécile Duplaà, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 35
Lauriane Cornuault, Paul Rouault, Cécile Duplaà, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 35
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
Antoni Bayés‐Genís, Alberto Aimo, Pardeep S. Jhund, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1767-1777
Open Access | Times Cited: 34
Antoni Bayés‐Genís, Alberto Aimo, Pardeep S. Jhund, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1767-1777
Open Access | Times Cited: 34
Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats
Jiung‐Pang Huang, Chih‐Chun Chang, Chao-Yu Kuo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7514-7514
Open Access | Times Cited: 30
Jiung‐Pang Huang, Chih‐Chun Chang, Chao-Yu Kuo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7514-7514
Open Access | Times Cited: 30
ST2 and the ST2/IL-33 signalling pathway–biochemistry and pathophysiology in animal models and humans
Irene Pusceddu, Benjamin Dieplinger, Thomas Mueller
Clinica Chimica Acta (2019) Vol. 495, pp. 493-500
Closed Access | Times Cited: 53
Irene Pusceddu, Benjamin Dieplinger, Thomas Mueller
Clinica Chimica Acta (2019) Vol. 495, pp. 493-500
Closed Access | Times Cited: 53
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
Bernadet T. Santema, Michelle Chan, Jasper Tromp, et al.
Clinical Research in Cardiology (2019) Vol. 109, Iss. 3, pp. 331-338
Open Access | Times Cited: 43
Bernadet T. Santema, Michelle Chan, Jasper Tromp, et al.
Clinical Research in Cardiology (2019) Vol. 109, Iss. 3, pp. 331-338
Open Access | Times Cited: 43
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 34
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 34
GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Qing-Ao Xiao, Qian He, Jun Zeng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112582-112582
Open Access | Times Cited: 32
Qing-Ao Xiao, Qian He, Jun Zeng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112582-112582
Open Access | Times Cited: 32
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology
Andrew J.S. Coats, Stéphane Heymans, Dimitrios Farmakis, et al.
European Heart Journal (2021) Vol. 43, Iss. 9, pp. 863-867
Open Access | Times Cited: 28
Andrew J.S. Coats, Stéphane Heymans, Dimitrios Farmakis, et al.
European Heart Journal (2021) Vol. 43, Iss. 9, pp. 863-867
Open Access | Times Cited: 28
DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters
Nienke M. Stege, Tim R. Eijgenraam, Vivian Oliveira Nunes Teixeira, et al.
Circulation Research (2023) Vol. 133, Iss. 12, pp. 1006-1021
Open Access | Times Cited: 12
Nienke M. Stege, Tim R. Eijgenraam, Vivian Oliveira Nunes Teixeira, et al.
Circulation Research (2023) Vol. 133, Iss. 12, pp. 1006-1021
Open Access | Times Cited: 12
Exploring the therapeutic potential of tetrahydrobiopterin for heart failure with preserved ejection fraction: A path forward
Weiyi Xia, Miao Zhang, Chang Liu, et al.
Life Sciences (2024) Vol. 345, pp. 122594-122594
Open Access | Times Cited: 4
Weiyi Xia, Miao Zhang, Chang Liu, et al.
Life Sciences (2024) Vol. 345, pp. 122594-122594
Open Access | Times Cited: 4
